angiotensin ii has been researched along with ST Elevated Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, S; Ding, M; Guan, L; Li, D; Li, Z; Liang, N; Liu, H | 1 |
| Barbato, E; Bellis, A; Di Gioia, G; Mauro, C; Morisco, C; Sorriento, D; Trimarco, B | 1 |
1 review(s) available for angiotensin ii and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
Topics: Adrenomedullin; Aminobutyrates; Angiotensin II; Animals; Apelin; Atrial Natriuretic Factor; Biphenyl Compounds; Bradykinin; Cardiotonic Agents; Drug Combinations; Gene Expression Regulation; Humans; Mice; Myocardial Reperfusion Injury; Neprilysin; ST Elevation Myocardial Infarction; Substance P; Survival Analysis; Tetrazoles; Valsartan; Ventricular Remodeling | 2020 |
1 other study(ies) available for angiotensin ii and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Associations of ACE I/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients.
Topics: Angiotensin II; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; INDEL Mutation; Interleukin-6; Kallikreins; Logistic Models; Male; Middle Aged; Multivariate Analysis; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Risk Factors; ST Elevation Myocardial Infarction | 2019 |